Article
Can microRNAs be Biomarkers or Targets for Therapy of Ischemic Coronary Artery Disease in Metabolic Syndrome?
Current drug targets - 1 Jan 2017
Rocic Petra
Abstract excerpt
BACKGROUND: Due to their exceptional stability in the circulation, microRNAs (miRs) are being identified as promising biomarkers. On the other hand, their propensity to regulate networks of functionally closely related genes and relative ease of delivery makes them attractive targets for therapy. However, neither application is without challenges, especially as it applies to ischemic coronary artery disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
